Building Effective Multi-Year Process Development Programs I: Estimating hMSC Lot Size Ranges for Clinical Manufacturing Through Commercial Demand March 16, 2021 BioEconomy, Biomanufacturing, Bioprocess Tools, Cell Therapy
Big Effects in Small Packages: What Are Extracellular Vesicles, Exosomes, & Microvesicles & Why Are They En Route to the Clinic? October 06, 2021 EVs & Exosomes
Maintaining CQAs as Manufacturing Processes are Scaled from 2D to 3D Bioreactor Culture February 28, 2022 Biomanufacturing, Quality & Regulatory
What Is Population Doubling Level (PDL) & Why Is It Important for Cell Age? September 29, 2021 MSCs & Characterization
BPI 2019: Scaling a Xeno-Free (XF) Fed-Batch Microcarrier Suspension Bioreactor System to the Production Scale (50L) for Manufacturing XF hMSCs Poster September 2019
CliniControl™ Products Compress Development Timelines for Cell-based Therapeutics Brochure October 2019
Aspiration-Assisted Bioprinting for Precise Positioning of Biologics March 2020 Bioprinting, MedTech, Devices, & Materials, Tissue & Organ Engineering
Sub-Nanoliter Metabolomics via Mass Spectrometry to Characterize Volume-Limited Samples November 2020 Bioprocess Tool Development
Multi-Peptide Presentation & Hydrogel Mechanics Jointly Enhance Therapeutic Duo-Potential of Entrapped Stromal Cells July 2020 Cardiovascular, Gene Editing, MedTech, Devices, & Materials, Orthopedic
Label-Free Separation of Mesenchymal Stem Cell Subpopulations with Distinct Differentiation Potencies & Paracrine Effects May 2020 EVs & MSC Secretome
A Multi-Niche Microvascularized Human Bone Marrow (hBM) On-A-Chip Elucidates Key Roles of the Endosteal Niche in hBM Physiology March 2021 Bioprocess Tool Development, Blood, MedTech, Devices, & Materials, Orthopedic, Tissue & Organ Engineering
Emerging Technologies & Commercial Products in Exosome-Based Cancer Diagnosis & Prognosis March 2021 Bioprocess Tool Development, Cancer, EVs & MSC Secretome
